Longeveron is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stephen H. Willard, with a market cap of $25.6M.
Based on Q1 2026 filing
Common questions about Longeveron
Longeveron (LGVN) has a market capitalization of $25.6M and trades on NASDAQ.
Longeveron has approximately 24 employees.